Clinical Trial Imaging Market 2021 - Global Analysis by Software & Services (Operational Imaging, Read Analysis), Modality, Therapeutic Areas, End-user, Growth Rate, and Competitive Landscape by 2026

Clinical Trial Imaging Market report offers the list of chief competitors and provides strategic insights and analysis of key factors influencing the industry. This market analysis makes businesses acquainted with various segments that are relied upon to observe the rapid business development amid the estimated forecast frame. This market research report has wide-ranging and comprehensive market insights which are based on business intelligence. This global Clinical Trial Imaging Market report best suits the requirements of clients. A panel of skilled analysts, well-versed statisticians, knowledgeable research experts, enthusiastic forecasters, and smart economists work carefully to generate such excellent market research reports for businesses.

Request for FREE Sample Report: To Know the Impact of COVID-19 on this Industry at: https://www.reportsnreports.com/contacts/requestsample.aspx?name=785426

The global clinical trial imaging market is projected to reach USD 1.4 billion by 2026 from USD 1.0 billion in 2021, at a CAGR of 7.6% during the forecast period. Market growth is driven by factors such as the growth in the pharmaceutical and biotechnology industries, increase in R&D spending and increasing number of CROs. On the other hand, the high implementation cost of imaging system and high cost of clinical trials are the major factors hampering the growth of this market.

Lists of Companies Profiled in the Report:

ICON plc. (Ireland)
BioTelemetry Inc. (US)
Biomedical Systems Corporation (US)
Medpace Holdings, Inc. (US)
IXICO plc. (UK)
Resonance Health Ltd. (Australia)
Radiant Sage LLC. (US)
BioClinica Inc. (US)
Intrinsic Imaging LLC. (US)
Cardiovascular Imaging Technologies LLC. (US)
Medical Metrics Inc. (US)
Prism Clinical Imaging, Inc. (US)
Boston Imaging Core Lab LLC. (US)
anagram 4 clinical trials (Spain)
Lyscaut Medical Imaging Company (Belgium)
Calyx Group (UK)
Bioseptive Inc. (Canada)
ProScan Imaging LLC. (US)
Micron Inc. (Japan)
Imaging Endpoints LI, LLC (US)
Perspectum Ltd. (UK)
PharmtraceklinischeEntwicklung GmbH (Germany)
WorldCare Clinical, LLC (US)

“The service segment accounted for the highest growth rate in the clinical trial imaging market, by product, during the forecast period”

The clinical trial imaging market is segmented into services and software based on product and service. In 2020, the service segment accounted for the highest growth rate in the clinical trial imaging market. increase in R&D spending and growth in pharmaceutical and biotechnology industries are major factor contributing to the growth of this segment.

“Medical device manufacturers segment accounted for the highest CAGR”

Based on end user, the clinical trial imaging market is segmented into pharmaceutical companies, biotechnology companies, medical devices manufacturers, contract research organizations, academic and government research institutes and other end users. In 2020, the medical device manufacturers segment accounted for the highest growth rate. This can be attributed to the increasing number of CROs, increase R&D spending and growth in the pharmaceutical and biotechnology industries.

“Asia Pacific: The fastest-growing region clinical trial imaging market”

The global clinical trial imaging market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Factors such as the growth in the pharmaceutical and biotechnology industries and increase in R&D spending are driving the growth of the clinical trial imaging market in this region.

The primary interviews conducted for this report can be categorized as follows:

By Company Type: Tier 1 - 40%, Tier 2 - 30%,and Tier 3 -30%
By Designation: C-level - 27%, D-level - 18%, and Others - 55%
By Region: North America -51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6%, and the Middle East & Africa – 4%

Research Coverage:

This report provides a detailed picture of the global clinical trial imaging market. It aims at estimating the size and future growth potential of the market across different segments, such as product and service, modality, therapeutic area, end-user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall clinical trial imaging market and its sub-segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

Get FLAT 20% Discount on this Report at: https://www.reportsnreports.com/purchase.aspx?name=785426

Table Of Contents

1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.2.1 Inclusions & Exclusions Of The Study
1.2.2 Markets Covered
Figure 1 Clinical Trial Imaging Market Segmentation
1.2.3 Years Considered For The Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders
1.6 Summary Of Changes

2 Research Methodology
2.1 Research Data
2.2 Research Approach
Figure 2 Clinical Trial Imaging Market: Research Design
2.2.1 Secondary Data
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Data
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Industry Insights
Figure 3 Breakdown Of Primary Interviews: By Company Type, Designation, And Region
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
Figure 4 Clinical Trial Imaging Market: Bottom-Up Approach
Figure 5 Cagr Projections: Supply-Side Analysis
2.3.2 Top-Down Approach
Figure 6 Clinical Trial Imaging Market: Top-Down Approach
2.4 Market Breakdown & Data Triangulation
Figure 7 Data Triangulation Methodology
2.5 Assumptions For The Study
2.6 Growth Rate Assumptions
2.7 Limitations
2.8 Risk Assessment
2.9 Covid-19 Health Assessment
2.10 Covid-19 Economic Assessment
2.10.1 Assessment Of The Impact Of Covid-19 On The Economic Scenario
Figure 8 Criteria Impacting The Global Economy
Figure 9 Recovery Scenario Of The Global Economy
2.10.2 Assessment Of The Impact Of Covid-19 On The Clinical Trial Imaging Market

3 Executive Summary
Figure 10 Clinical Trial Imaging Market, By Product And Service, 2021 Vs. 2026 (Usd Million)
Figure 11 Clinical Trial Imaging Market, By Modality, 2021 Vs. 2026 (Usd Million)
Figure 12 Clinical Trial Imaging Market, By Therapeutic Area, 2021 Vs. 2026 (Usd Million)
Figure 13 Clinical Trial Imaging Market, By End User, 2021 Vs. 2026 (Usd Million)
Figure 14 Clinical Trial Imaging Market, By Region, 2021 Vs. 2026 (Usd Million)

4 Premium Insights
4.1 Clinical Trial Imaging Market Overview
Figure 15 Increase In R&D Spending To Drive Market Growth
4.2 Clinical Trial Imaging Market Share, By Product & Service, 2021 Vs. 2026
Figure 16 Services Will Continue To Dominate The Market In 2026
4.3 Clinical Trial Imaging Market Share, By Modality, 2021 Vs. 2026
Figure 17 Computed Tomography To Dominate The Market During The Forecast Period
4.4 Clinical Trial Imaging Market Share, By Therapeutic Area, 2021 Vs. 2026
Figure 18 Oncology Is The Largest Segment In The Clinical Trial Imaging Market By Therapeutic Area
4.5 Clinical Trial Imaging Market Share, By End User, 2021 Vs. 2026
Figure 19 Pharmaceutical Companies Form The Largest End Users Of The Clinical Trial Imaging Market
4.6 Clinical Trial Imaging Market: Geographic Growth Opportunities
Figure 20 Asia Pacific To Register The Highest Growth Rate In The Clinical Trial Imaging Market During The Forecast Period

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 21 Clinical Trial Imaging Market: Drivers, Restraints, Opportunities, And Challenges
5.2.1 Drivers
5.2.1.1 Increasing R&D Spending
5.2.1.2 Growth In The Pharmaceutical And Biotechnology Industries
5.2.1.3 Increasing Number Of Cros
5.2.2 Restraints
5.2.2.1 High Implementation Cost Of Imaging Systems
5.2.3 Opportunities
5.2.3.1 Developing Countries
5.2.3.2 Development Of Innovative Imaging Modalities, Contrast Agents, Molecular Probes, And Radiopharmaceuticals
5.2.4 Challenges
5.2.4.1 High Cost Of Clinical Trials
5.3 Impact Of Covid-19 On The Clinical Trial Imaging Market
5.4 Pricing Analysis
Table 1 Prices Of Clinical Trial Imaging Products (2021)
5.5 Patent Analysis
5.6 Trade Analysis
5.6.1 Trade Analysis For X-Ray Apparatuses
Table 2 Import Data For X-Ray Apparatuses, By Country, 2016–2020 (Usd Million)
Table 3 Export Data For X-Ray Apparatuses, By Country, 2016–2020 (Usd Million)
5.6.2 Trade Analysis For Ct Apparatuses
Table 4 Import Data For Ct Apparatuses, By Country, 2016–2020 (Usd Million)
Table 5 Export Data For Ct Apparatuses, By Country, 2016–2020 (Usd Million)
5.7 Value Chain Analysis
Figure 22 Major Value Is Added During The Development And Procurement Phases
5.8 Supply Chain Analysis
Figure 23 Distribution—A Strategy Preferred By Prominent Companies
5.9 Ecosystem Analysis Of The Clinical Trial Imaging Market
Figure 24 Clinical Trial Imaging Market: Ecosystem Analysis
5.9.1 Role In The Ecosystem
5.10 Porter’s Five Forces Analysis
Table 6 Clinical Trial Imaging Market: Porter’s Five Forces Analysis
5.10.1 Threat Of New Entrants
5.10.2 Threat Of Substitutes
5.10.3 Bargaining Power Of Buyers
5.10.4 Bargaining Power Of Suppliers
5.10.5 Degree Of Competition
5.11 Pestle Analysis
5.12 Regulatory Landscape
5.12.1 North America
5.12.1.1 Us
5.12.1.2 Canada
5.12.2 Europe
5.12.3 Asia Pacific
5.12.3.1 Japan
5.12.3.2 India
5.12.3.3 China
5.12.4 Latin America
5.12.4.1 Brazil
5.12.4.2 Mexico
5.12.5 Middle East
5.12.6 Africa
5.13 Technology Analysis
5.14 Disruptive Technologies In The Clinical Trial Imaging Market
5.14.1 Revenue Shift & Revenue Pockets For The Clinical Trial Imaging Market
Figure 25 Revenue Shift For The Clinical Trial Imaging Market

6 Clinical Trial Imaging Market, By Product & Service

7 Clinical Trial Imaging Market, By Modality

8 Clinical Trial Imaging Market, By Therapeutic Area

9 Clinical Trial Imaging Market, By End User

10 Clinical Trial Imaging Market, By Region

11 Competitive Landscape

Enquire Here for, Report Enquiry, Discount and Customization at: https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=785426

Contact Us:

Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com

About Us:

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

This release was published on openPR.